1. Home
  2. AIO vs YDES Comparison

AIO vs YDES Comparison

Compare AIO & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virtus Artificial Intelligence & Technology Opportunities Fund of Beneficial Interest

AIO

Virtus Artificial Intelligence & Technology Opportunities Fund of Beneficial Interest

HOLD

Current Price

$23.01

Market Cap

777.8M

Sector

Finance

ML Signal

HOLD

YDES

YD Bio Limited Ordinary Shares

N/A

Current Price

$8.69

Market Cap

894.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
AIO
YDES
Founded
2019
2013
Country
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
777.8M
894.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AIO
YDES
Price
$23.01
$8.69
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
111.6K
28.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
9.05%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.18
$7.90
52 Week High
$25.47
$25.00

Technical Indicators

Market Signals
Indicator
AIO
YDES
Relative Strength Index (RSI) 55.88 27.67
Support Level $22.34 $9.76
Resistance Level $22.90 $11.80
Average True Range (ATR) 0.42 0.84
MACD 0.04 -0.29
Stochastic Oscillator 84.93 2.95

Price Performance

Historical Comparison
AIO
YDES

About AIO Virtus Artificial Intelligence & Technology Opportunities Fund of Beneficial Interest

Virtus Artificial Intelligence & Technology Opportunities Fund is a diversified, limited-term, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income, current gains, and long-term capital appreciation.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: